Order Article Reprints

Schreiber F, Piontek G, Schneider-Kimoto Y, Schwarz-Furlan S, De Vito R, Locatelli F, Gengler C, Yoshimi A, Jung A, Klauschen F, et al. Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation. Cancers. 2023; 15(23):5594. https://doi.org/10.3390/cancers15235594

Schreiber, Franziska, Guido Piontek, Yuki Schneider-Kimoto, Stephan Schwarz-Furlan, Rita De Vito, Franco Locatelli, Carole Gengler, Ayami Yoshimi, Andreas Jung, Frederick Klauschen, and et al. 2023. "Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation" Cancers 15, no. 23: 5594. https://doi.org/10.3390/cancers15235594

Schreiber, F., Piontek, G., Schneider-Kimoto, Y., Schwarz-Furlan, S., De Vito, R., Locatelli, F., Gengler, C., Yoshimi, A., Jung, A., Klauschen, F., Niemeyer, C. M., Erlacher, M., & Rudelius, M. (2023). Development of MDS in Pediatric Patients with GATA2 Deficiency: Increased Histone Trimethylation and Deregulated Apoptosis as Potential Drivers of Transformation. Cancers, 15(23), 5594. https://doi.org/10.3390/cancers15235594